Robot model
Myomo MyoPro
Powered (motor-actuated) upper-limb orthosis controlled by the user's own EMG (myoelectric) muscle signals: faint bicep/tricep signals trigger powered…
- Manufacturer
- Myomo
- Form factor
- exoskeleton
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 2
- Website
- myomo.com ↗
The verified answer
As of Sep 2026, DEPLOY verifies Myomo MyoPro, a exoskeleton by Myomo (commercial): 2 verified deployments on record. 2 sources back the record.
Overview
Powered (motor-actuated) upper-limb orthosis controlled by the user's own EMG (myoelectric) muscle signals: faint bicep/tricep signals trigger powered elbow/hand assistance for people with arm paralysis. FDA 510(k) cleared (K062631). Powered, user-EMG-controlled.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Robot
Focus
Origin
Founded
CEO
Product
Listed on
Application
Specs
Use
Control
Powered
Regulatory
Body region
Availability
Data & sources
Web sources
2
2 sources backing this record.View all →
Pricing
No verified price is on record for Myomo MyoPro. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (2)
Commercial product — available for purchase in this market.
- Myomo MyoPro at Germany, Europeoperational
Commercial product — available for purchase in this market.
Myomo MyoPro on the deployment map
View the global mapWhere Myomo MyoPro is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 11, 2026
Myomo MyoPro device for stroke arm recovery
- Record createdJun 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
at United States (multiple hotel chains)
- Deployment verifiedVerifiedJun 1, 2024
at Germany, Europe
Safety record
No incidents on record for Myomo MyoPro.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (2)
Common questions
What is Myomo MyoPro?
How much does Myomo MyoPro cost?
Is Myomo MyoPro actually deployed in the real world?
Who makes Myomo MyoPro?
Where is Myomo MyoPro deployed?
Can you buy Myomo MyoPro?
What are alternatives to Myomo MyoPro?
How does Myomo MyoPro compare to Ant-H1 Pro?
Is Myomo MyoPro a top exoskeleton?
What is Myomo MyoPro's maturity stage?
Is Myomo MyoPro safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-08
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-08
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Myomo MyoPro.Recent coverage
Myomo MyoPro in third-party press
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis - Medical Economics
Myomo to raise $6M with eyes on Medicare coverage - MassDevice
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Myomo MyoPro from third-party publications. Automatically surfaced; not part of the verified registry record.
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
<a…
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis - Medical Economics
<a…
Myomo to raise $6M with eyes on Medicare coverage - MassDevice
<a…
Myomo prices $4.4M offering, scores reimbursement win - MassDevice
<a…
Myomo prices $6.5M public offering - MassDevice
<a…
Myomo touts independent study of its MyoPro myoelectric orthosis - MassDevice
<a…
Myomo scales up production, training for MyoPro device for upper-body mobility - The Robot Report
<a…
High-tech device helps young man compensate for arm injury - Akron Beacon Journal
<a…
MyoPro the Assistive Arm Exoskeleton by Myomo Featured in SolidWorks - Exoskeleton Report
<a…
Machine-readable surfaces
- Markdown mirror: /models/myomo-myopro.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/9a6f03e0-9428-40a7-b0ad-cf8c85071e85
- Revision history: /models/myomo-myopro/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Myomo MyoPro draws attention at the 49th percentile but verifies reality at the 61st percentile among exoskeletons. Hype Gap -12.2, 28th widest among exoskeletons.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 6, 2026